Chemokine receptor antagonists and methods of use therefor
US6509346B2 · kind B2 · utility
13Cited by
36References
83Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 28, 1999 |
| Grant date | Jan 21, 2003 |
| Priority date | — |
| Expiry date | Sep 2, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by: and physiologically acceptable salts thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.